Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to 0.79.

  • Bristol Myers Squibb's FCF Payout Ratio rose 16232.56% to 0.79 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.39, marking a year-over-year increase of 1260.25%. This contributed to the annual value of 0.39 for FY2025, which is 1260.25% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's FCF Payout Ratio is 0.79, which was up 16232.56% from 0.21 recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's FCF Payout Ratio peaked at 0.79 during Q4 2025, and registered a low of 0.0 during Q2 2021.
  • Over the past 5 years, Bristol Myers Squibb's median FCF Payout Ratio value was 0.32 (recorded in 2021), while the average stood at 0.37.
  • Per our database at Business Quant, Bristol Myers Squibb's FCF Payout Ratio crashed by 9880.08% in 2021 and then soared by 1208690.11% in 2023.
  • Over the past 5 years, Bristol Myers Squibb's FCF Payout Ratio (Quarter) stood at 0.29 in 2021, then skyrocketed by 31.53% to 0.39 in 2022, then fell by 23.54% to 0.3 in 2023, then rose by 1.41% to 0.3 in 2024, then skyrocketed by 162.33% to 0.79 in 2025.
  • Its last three reported values are 0.79 in Q4 2025, 0.21 for Q3 2025, and 0.35 during Q2 2025.